GE HealthCare Technologies Inc. (GEHC)
Cash ratio
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | ||
---|---|---|---|---|
Cash and cash equivalents | US$ in thousands | 2,874,000 | 2,494,000 | 1,440,000 |
Short-term investments | US$ in thousands | 15,000 | — | — |
Total current liabilities | US$ in thousands | 9,553,000 | 8,981,000 | 7,191,000 |
Cash ratio | 0.30 | 0.28 | 0.20 |
December 31, 2024 calculation
Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($2,874,000K
+ $15,000K)
÷ $9,553,000K
= 0.30
The cash ratio of GE HealthCare Technologies Inc. has shown an increasing trend over the three years analyzed. As of December 31, 2022, the cash ratio stood at 0.20, indicating that the company had $0.20 in cash for every $1 of current liabilities. By December 31, 2023, the ratio had improved to 0.28, signifying a stronger liquidity position. Furthermore, as of December 31, 2024, the cash ratio continued to rise to 0.30, reflecting the company's ability to meet its short-term obligations with cash on hand. This positive progression suggests that GE HealthCare Technologies Inc. has been managing its liquidity effectively and may have sufficient liquid assets to cover its current liabilities in the future.
Peer comparison
Dec 31, 2024